BMS-202448

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBMS-202448
Drug Alias Namegp39-antibody (BMS)BMS-202448
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseArthritis

Other Information

ATC CodeN/A
Related LinksN/A